Market intelligence for life science
Every trial, paper, partnership and approval, joined to the companies, labs and people behind it, with a link to the source on every line. With support from a commercial operator to turn it into decisions.
Recent headlines from the trade press, refreshed with each update.
Updated Oct 6, 2026 · headlines link to the publisher
Start with a map, plug the data into your own AI, or bring us a decision. Each is built on the same connected, sourced record.
Interactive maps of a field: who runs which trials where, which companies partner with whom, what is approved, and what methods labs actually use.
Available atlases
The connected graph behind the atlases (deals, companies, trials, papers, funding), delivered as an API and a connector your own AI can query, with sources attached.
For life-science tools, diagnostics and biotech teams: product and commercial strategy, R&D decisions, market landscapes, competitive and acquirer analysis, launch and go-to-market, built on the data rather than opinion.
Most market data asks you to trust the analyst. Here every trial, deal, approval and paper links to its primary source, so you can check it in one click and quote it with confidence.
"MD Anderson ran 172 cell therapy trials, more than any other center."
Abe Couse
I’ve spent my career launching and marketing life-science products. Now I build the evidence layer to inform those decisions, and we use it with clients: landscapes, positioning, partnering and launch for life-science tools and therapeutics companies.
Bring me a question you need answered or a decision you’re facing, and I’ll build the analysis around it.